17-30222880-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001045.6(SLC6A4):c.-185C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.806 in 1,299,148 control chromosomes in the GnomAD database, including 422,562 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.78 ( 46989 hom., cov: 33)
Exomes 𝑓: 0.81 ( 375573 hom. )
Consequence
SLC6A4
NM_001045.6 5_prime_UTR
NM_001045.6 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.543
Genes affected
SLC6A4 (HGNC:11050): (solute carrier family 6 member 4) This gene encodes an integral membrane protein that transports the neurotransmitter serotonin from synaptic spaces into presynaptic neurons. The encoded protein terminates the action of serotonin and recycles it in a sodium-dependent manner. This protein is a target of psychomotor stimulants, such as amphetamines and cocaine, and is a member of the sodium:neurotransmitter symporter family. A repeat length polymorphism in the promoter of this gene has been shown to affect the rate of serotonin uptake. There have been conflicting results in the literature about the possible effect, if any, that this polymorphism may play in behavior and depression. [provided by RefSeq, May 2019]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-30222880-G-T is Benign according to our data. Variant chr17-30222880-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 322546.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.866 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A4 | NM_001045.6 | c.-185C>A | 5_prime_UTR_variant | 2/15 | ENST00000650711.1 | NP_001036.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A4 | ENST00000650711.1 | c.-185C>A | 5_prime_UTR_variant | 2/15 | NM_001045.6 | ENSP00000498537.1 | ||||
SLC6A4 | ENST00000261707.7 | c.-185C>A | 5_prime_UTR_variant | 2/15 | 1 | ENSP00000261707.3 | ||||
SLC6A4 | ENST00000394821.2 | c.-185C>A | 5_prime_UTR_variant | 2/15 | 1 | ENSP00000378298.2 | ||||
SLC6A4 | ENST00000401766.6 | c.-123-799C>A | intron_variant | 5 | ENSP00000385822.2 |
Frequencies
GnomAD3 genomes AF: 0.784 AC: 119208AN: 152102Hom.: 46974 Cov.: 33
GnomAD3 genomes
AF:
AC:
119208
AN:
152102
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.809 AC: 927348AN: 1146928Hom.: 375573 Cov.: 24 AF XY: 0.809 AC XY: 455059AN XY: 562700
GnomAD4 exome
AF:
AC:
927348
AN:
1146928
Hom.:
Cov.:
24
AF XY:
AC XY:
455059
AN XY:
562700
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.784 AC: 119270AN: 152220Hom.: 46989 Cov.: 33 AF XY: 0.786 AC XY: 58512AN XY: 74422
GnomAD4 genome
AF:
AC:
119270
AN:
152220
Hom.:
Cov.:
33
AF XY:
AC XY:
58512
AN XY:
74422
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2874
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Behavior disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at